Ellevest, Inc. Beyond Spring Inc. Transaction History

Ellevest, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	BUY	$1.13 - $2.66 $124 - $292	110 Added 81.48%	245 $0
Q1 2022 Apr 19, 2022	BUY	$1.68 - $5.01 $75 - $225	45 Added 50.0%	135 $0
Q4 2021 Jan 24, 2022	BUY	$4.02 - $16.84 $301 - $1,263	75 Added 500.0%	90 $0
Q3 2021 Oct 19, 2021	BUY	$9.26 - $31.31 $138 - $469	15 New	15 $0
Q2 2020 Jul 06, 2020	SELL	$11.21 - $18.15 $11 - $18	-1 Closed	0 $0
Q1 2020 Apr 13, 2020	BUY	$9.68 - $18.47 $9 - $18	1 New	1 $0

5.77M

53.2K

2.5K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $91.5M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.